Showing results (281-290 of 520) with videos related to
Sort By:
Pageof 52
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 14, 2008
Pre-emptive conditioning of the ischemic heartJoseph M Vitale, Hongyu Qiu, Christophe DepreCardiovascular & Hematological Agents in Medicinal Chemistry|May 14, 2008
Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stentingThomas J Kiernan, Bryan P Yan, Ignacio Cruz-Gonzalez, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|May 14, 2008
Pharmacological approach of no-reflow phenomenon related with percutaneous coronary interventionsS Jiménez Valero, R Moreno, R Martin Reyes, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|November 11, 2024
A Comprehensive Insight on Pharmacological Properties of Cilnidipine: A Fourth-generation Calcium Channel BlockerRenu Kadian, Arun NandaCardiovascular & Hematological Agents in Medicinal Chemistry|August 29, 2024
The Effect of CD31 on Coronary Collateral DevelopmentHuseyin Akcali, Mustafa Begenc Tascanov, Kenan Toprak, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2006
Inflammation in cardiovascular disease and regulation of the actin cytoskeleton in inflammatory cells: the actin cytoskeleton as a targetT H Thomas, A AdvaniCardiovascular & Hematological Agents in Medicinal Chemistry|July 18, 2006
Antiplatelet and antileukocyte effects of cardiovascular, immunomodulatory and chemotherapeutic drugsRado NosalCardiovascular & Hematological Agents in Medicinal Chemistry|February 3, 2007
Neoangiogenesis induced by progenitor endothelial cells: effect of fucoidan from marine algaeC Boisson-Vidal, F Zemani, G Caligiuri, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|February 3, 2007
Cardiac ATP-sensitive potassium channels: a potential target for an anti-ischaemic pharmacological strategyL Testai, S Rapposelli, V CalderoneCardiovascular & Hematological Agents in Medicinal Chemistry|February 3, 2007
The therapeutic potential of phospholipase A2 inhibitors in cardiovascular diseaseM C White, J McHowatPageof 52